| known also as: |
Anti-Goat Polyclonal to Human APOA2 / Apolipoprotein A II |
| known also as: |
Caprine PAb to Human APOA2 / Apolipoprotein A II |
| known also as: |
Caprinae Polyclonal to Homo sapiens APOA2 / Apolipoprotein A II |
| known also as: |
APOA2 / Apolipoprotein A II |
| known also as: |
APOA2, Apo-AII, ApoA-II, ApoAII, Apolipoprotein A II, Apolipoprotein A II, Apolipoprotein A-II, Apolipoprotein A2, Human APOA2, Anti-APOA2 / Apolipoprotein A II Antibody IHC-plus |
| Other names: |
Apolipoprotein A-II, Apolipoprotein A2Cleaved into the following 2 chains:Proapolipoprotein A-II, ProapoA-II, Truncated apolipoprotein A-IIAlternative name(s):Apolipoprotein A-II(1-76), apolipoprotein A-II, apolipoprotein A-II, apolipoprotein A2, apolipoprotein A-II preproprotein |
| Gene name: |
APOA2 |
| Other gene names: |
APOA2, Apo-AII, Apo-AII, ApoA-II, ApoA-II, ProapoA-II, apoAII, APOA2 |
| Category: |
Antibodies |
| Clonality: |
Polyclonal |
| Clone: |
Polyclonal antibody |
| Host organism: |
Goat |
| Species reactivity: |
Human |
| Specificity and cross-reactivity: |
B, C-I, C-II, C-III, E and J apolipoproteins, Non-specific cross reaction of anti-apolipoprotein antibodies with other human serum proteins is negligible, Specific cross reaction of anti-apolipoprotein antibodies with antigens from other species has not been determined, This antibody reacts with human apolipoprotein A-II and has negligible cross-reactivity with Type A-I, other types of apolipoprotein was detected by ELISA against purified standards |
| Purification method: |
Protein A Purified |
| Form/Appearance: |
0, 0, 0, pH 8, 005 M EDTA, 01% sodium azide, 075 M sodium chloride, 125 M sodium borate |
| Concentration: |
1 miligram per 1 mililiter |
| Storage and shipping: |
Dilute only prior to immediate use, For extended storage mix with an equal volume of glycerol, aliquot contents and freeze at -20 C or below, as an undiluted liquid, prior to opening, productone is stable Store productone at +4 degrees Celsius, Store vial at Store productone at +4 degrees Celsius |
| Tested for:: |
ELISA (EIA), Immunoprecipitation (IP), Western Blot (WB), Immunohistochemistry (IHC - Paraffin) |
| Description: |
Polyclonal antibodies generally are more stable and retain their reactivity under unfavorable conditions, Polyclonal antibodies have series of advantages - larger batches can be supplied at a time, Properly used, To obtain more detailed information on productone, please, refer to the full product datasheet, the time needed for production is considerably shorter, they are inexpensive to manufacture and respectively to buy, this antibody will ensure excellent and reproducible results with guaranteed success for the applications that it is tested in, productone is a polyclonal antibody of high purity and binding affinity for the antigen that it is risen against |
| Advisory: |
For antibodies that are in liquid form or reconstituted lyophilized antibodies small amounts could become entrapped on the seal or the walls of the tube, Prior to use briefly centrifuge the vial to gather all the solution on the bottom, avoid cycles of freezing and thawing, please, In order to retain the quality and the affinity of productone unchanged |
| Properties: |
Depending on the epitopes used human ELISA kits can be cross reactive to many other species, Human proteins, Mainly analyzed are human serum, Modern , cDNA and human recombinants are used in human reactive ELISA kits and to produce anti-human mono and polyclonal antibodies, human cell culture supernatants and biological samples, plasma, primarily , saliva, urine, , (Homo sapiens, C, C for long term storage and for short term at + 5°, Homo sapiens sapiens), If you buy Antibodies supplied by MBS Polyclonals_1 they should be stored frozen at - 24°, humans , ssp |
| Latin name: |
Capra aegagrus hircus |
| Group: |
Polyclonals and antibodies |
| About: |
The advantage is that there are more epitopes available in a polyclonal antiserum to detect the proteins than in monoclonal sera, immunohistochemistry on frozen slices or parrafin fixed tissues, Polyclonals can be used for Western blot |
| Gene target: |
APOA2 / Apolipoprotein A II |
| Short name: |
Goat Polyclonal APOA2 / Apolipoprotein A II Antibody |
| Technique: |
Pabs are a collection of immunoglobulin , Polyclonal antibodies , antibodies against human proteins, antibodies for, each identifying a different , goats, whereas , (pAbs) are mostly rabbit or goat , B cells, Polyclonal, antibodies , antigen, come from a single N cell lineage, epitope, molecules that react against a specific , monoclonal antibodies , that are secreted by different |
| Host: |
It are very good secondary antibodies that are affinity purified and have a good affinity themselves too, Often KLH is coupled to the antigen so anti KLH can be present in the vial, The goat polyclonal antibodies are directed against human genes or rabbit or mouse IgGs (H +L) chain primary antibodies and conjugated for detection, Goat |
| Species: |
Goats, Humans, Human |
| Alternative name: |
sapiens apolipoprotein A-II / Apolipoprotein A II (Antibody to), caprine polyclonal to H |
| Alternative technique: |
polyclonals |
| Alternative to gene target: |
APOA2 and IDBG-104234 and ENSG00000158874 and 336, APOA2 and IDBG-630130 and ENSBTAG00000009212 and 505394, Apo-AII and ApoA-II and apoAII, Apoa2 and IDBG-204212 and ENSMUSG00000005681 and 11807, Extracellular, high-density lipoprotein particle receptor binding, this GO :0001523 and retinoid metabolic process and biological process this GO :0002526 and acute inflammatory response and biological process this GO :0002740 and negative regulation of cytokine secretion involved in immune response and biological process this GO :0005319 and lipid transporter activity and molecular function this GO :0005515 and protein binding and molecular function this GO :0005543 and phospholipid binding and molecular function this GO :0005576 and extracellular region and cellular component this GO :0005615 and extracellular space and cellular component this GO :0005769 and early endosome and cellular component this GO :0005788 and endoplasmic reticulum lumen and cellular component this GO :0005829 and cytosol and cellular component this GO :0006457 and protein folding and biological process this GO :0006641 and triglyceride metabolic process and biological process this GO :0006656 and phosphatidylcholine biosynthetic process and biological process this GO :0006869 and lipid transport and biological process this GO :0007603 and phototransduction, this GO :0005319 : lipid transporter activity, this GO :0005319 : lipid transporter activity and also this GO :0005515 : protein binding and also this GO :0005543 : phospholipid binding and also this GO :0008035 : high-density lipoprotein particle binding and also this GO :0008289 : lipid binding and also this GO :0015485 : cholesterol binding and also this GO :0017127 : cholesterol transporter activity and also this GO :0031210 : phosphatidylcholine binding and also this GO :0034190 : apolipoprotein receptor binding and also this GO :0042803 : protein homodimerization activity and also this GO :0046982 : protein heterodimerization activity and also this GO :0055102 : lipase inhibitor activity and also this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity and also this GO :0070653 : high-density lipoprotein particle receptor binding, this GO :0005515 : protein binding, this GO :0005543 : phospholipid binding, this GO :0008035 : high-density lipoprotein particle binding, this GO :0008289 : lipid binding, this GO :0015485 : cholesterol binding, this GO :0017127 : cholesterol transporter activity, this GO :0031210 : phosphatidylcholine binding, this GO :0034190 : apolipoprotein receptor binding, this GO :0042803 : protein homodimerization activity, this GO :0046982 : protein heterodimerization activity, this GO :0055102 : lipase inhibitor activity, this GO :0060228 : phosphatidylcholine-sterol O-acyltransferase activator activity, this GO :0070653 : high-density lipoprotein particle receptor binding, visible light and biological process this GO :0008035 and high-density lipoprotein particle binding and molecular function this GO :0008203 and cholesterol metabolic process and biological process this GO :0008289 and lipid binding and molecular function this GO :0009395 and phospholipid catabolic process and biological process this GO :0009749 and response to glucose and biological process this GO :0010873 and positive regulation of cholesterol esterification and biological process this GO :0010903 and negative regulation of very-low-density lipoprotein particle remodeling and biological process this GO :0015485 and cholesterol binding and molecular function this GO :0016032 and viral process and biological process this GO :0017127 and cholesterol transporter activity and molecular function this GO :0018158 and protein oxidation and biological process this GO :0018206 and peptidyl-methionine modification and biological process this GO :0030300 and regulation of intestinal cholesterol absorption and biological process this GO :0030301 and cholesterol transport and biological process this GO :0031100 and organ regeneration and biological process this GO :0031210 and phosphatidylcholine binding and molecular function this GO :0031647 and regulation of protein stability and biological process this GO :0032375 and negative regulation of cholesterol transport and biological process this GO :0033344 and cholesterol efflux and biological process this GO :0033700 and phospholipid efflux and biological process this GO :0034190 and apolipoprotein receptor binding and molecular function this GO :0034361 and very-low-density lipoprotein particle and cellular component this GO :0034364 and high-density lipoprotein particle and cellular component this GO :0034366 and spherical high-density lipoprotein particle and cellular component this GO :0034370 and triglyceride-rich lipoprotein particle remodeling and biological process this GO :0034374 and low-density lipoprotein particle remodeling and biological process this GO :0034375 and high-density lipoprotein particle remodeling and biological process this GO :0034380 and high-density lipoprotein particle assembly and biological process this GO :0034384 and high-density lipoprotein particle clearance and biological process this GO :0042157 and lipoprotein metabolic process and biological process this GO :0042493 and response to drug and biological process this GO :0042627 and chylomicron and cellular component this GO :0042632 and cholesterol homeostasis and biological process this GO :0042803 and protein homodimerization activity and molecular function this GO :0043085 and positive regulation of catalytic activity and biological process this GO :0043627 and response to estrogen and biological process this GO :0043691 and reverse cholesterol transport and biological process this GO :0044255 and cellular lipid metabolic process and biological process this GO :0044281 and small molecule metabolic process and biological process this GO :0045416 and positive regulation of interleukin-8 biosynthetic process and biological process this GO :0046340 and diacylglycerol catabolic process and biological process this GO :0046982 and protein heterodimerization activity and molecular function this GO :0050995 and negative regulation of lipid catabolic process and biological process this GO :0050996 and positive regulation of lipid catabolic process and biological process this GO :0051384 and response to glucocorticoid and biological process this GO :0055102 and lipase inhibitor activity and molecular function this GO :0060192 and negative regulation of lipase activity and biological process this GO :0060228 and phosphatidylcholine-sterol O-acyltransferase activator activity and molecular function this GO :0060621 and negative regulation of cholesterol import and biological process this GO :0060695 and negative regulation of cholesterol transporter activity and biological process this GO :0070062 and extracellular vesicular exosome and cellular component this GO :0070653 and high-density lipoprotein particle receptor binding and molecular function this GO :0072562 and blood microparticle and cellular component, apolipoprotein A-II |
| Identity: |
601 |
| Gene: |
APOA2 |
More about : APOA2 |
| Long gene name: |
apolipoprotein A2 |
| Synonyms gene name: |
apolipoprotein A-II |
| Locus: |
1q23, 3 |
| Discovery year: |
2001-06-22 |
| Entrez gene record: |
336 |
| Pubmed identfication: |
2415515 |
| RefSeq identity: |
NM_001643 |
| Classification: |
Apolipoproteins |
| Havana BLAST/BLAT: |
OTTHUMG00000034346 |